Clinical trials
Carcinoid Tumor trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2010 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Unknown status | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
| No longer available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| British Columbia Cancer Agency | 4 |
| Novartis Pharmaceuticals | 3 |
| RayzeBio, Inc. | 2 |
| University of Western Ontario, Canada | 2 |
| CHU de Quebec-Universite Laval | 1 |
| Crinetics Pharmaceuticals Inc. | 1 |
| Sunnybrook Health Sciences Centre | 1 |
| Vancouver Coastal Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoid Tumor | 15 |
| Neuroendocrine Tumors | 8 |
| Neuroblastoma | 4 |
| Paraganglioma | 4 |
| Insulinoma | 3 |
| Pheochromocytoma | 3 |
| Adenoma, Islet Cell | 2 |
| Carcinoma, Medullary | 2 |
| Carcinoma, Neuroendocrine | 2 |
| Gastrinoma | 2 |
Trials
Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.